Georgian medical news · 2026
IATROGENIC PNEUMOTHORAX: ETIOLOGY, CLINICAL AND THERAPEUTIC ASPECTS.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Boukat A, Hammoumi M, Sarboute Y, Kabiri E
Аннотация
UNLABELLED: The development of invasive thoracic procedures performed for diagnostic and/or therapeutic purposes is associated with an increased incidence of iatrogenic pneumothorax.
OBJECTIVE: To describe the causes, clinical manifestations, and treatment modalities of iatrogenic pneumothorax, with the aim of better understanding the issues related to their prevention and management.
PATIENTS AND METHODS: Prospective descriptive and analytical observational study with active case notification conducted over a two-year period, from April 1, 2023, to April 1, 2025, at the Mohammed V Military Hospital in Rabat, including all patients with clinically and/or radiologically confirmed iatrogenic pneumothorax.
RESULTS: The study included 82 patients who presented with iatrogenic pneumothorax. The median age was 65 years [54; 70], with extremes ranging from 16 to 92 years. Of the patients, 50 (61%) were male and 32 (39%) female. The procedure causing iatrogenic pneumothorax was mainly therapeutic in 50 (61%). 45 (54.9%) patients had an underlying pulmonary pathology and 37 (45.1%) had an underlying extra-pulmonary pathology. The most frequent causes of iatrogenic pneumothorax were central venous catheterization in 34 (41.5%), followed by CT-guided transthoracic lung biopsy in 17 (20.7%) and barotrauma by mechanical ventilation in 11 (13.4%). The most frequent type of treatment was tube thoracostomy with or without needle aspiration in 45 cases (54.9%), followed by conservative treatment in 30 cases (36.6%). Follow-up under these different types of treatment was complicated in 20.7% of cases. Except for mobilization of the chest drain in the management of pneumothorax persisting beyond 7 days, 5 patients had benefited from pleurodesis, including one in the patient's bed and four by uni-portal video-assisted thoracic surgery (U-VATS). Seven patients out of the 82 cases died, i.e. 8.5%, and there was a statistically significant association between ASA Score and mortality with a P-value of 0.01.
CONCLUSION: The increasing frequency of iatrogenic pneumothorax requires heightened vigilance. Identifying and preventing avoidable risk factors must be a priority in order to limit its incidence and strengthen the safety of interventional practices.
OBJECTIVE: To describe the causes, clinical manifestations, and treatment modalities of iatrogenic pneumothorax, with the aim of better understanding the issues related to their prevention and management.
PATIENTS AND METHODS: Prospective descriptive and analytical observational study with active case notification conducted over a two-year period, from April 1, 2023, to April 1, 2025, at the Mohammed V Military Hospital in Rabat, including all patients with clinically and/or radiologically confirmed iatrogenic pneumothorax.
RESULTS: The study included 82 patients who presented with iatrogenic pneumothorax. The median age was 65 years [54; 70], with extremes ranging from 16 to 92 years. Of the patients, 50 (61%) were male and 32 (39%) female. The procedure causing iatrogenic pneumothorax was mainly therapeutic in 50 (61%). 45 (54.9%) patients had an underlying pulmonary pathology and 37 (45.1%) had an underlying extra-pulmonary pathology. The most frequent causes of iatrogenic pneumothorax were central venous catheterization in 34 (41.5%), followed by CT-guided transthoracic lung biopsy in 17 (20.7%) and barotrauma by mechanical ventilation in 11 (13.4%). The most frequent type of treatment was tube thoracostomy with or without needle aspiration in 45 cases (54.9%), followed by conservative treatment in 30 cases (36.6%). Follow-up under these different types of treatment was complicated in 20.7% of cases. Except for mobilization of the chest drain in the management of pneumothorax persisting beyond 7 days, 5 patients had benefited from pleurodesis, including one in the patient's bed and four by uni-portal video-assisted thoracic surgery (U-VATS). Seven patients out of the 82 cases died, i.e. 8.5%, and there was a statistically significant association between ASA Score and mortality with a P-value of 0.01.
CONCLUSION: The increasing frequency of iatrogenic pneumothorax requires heightened vigilance. Identifying and preventing avoidable risk factors must be a priority in order to limit its incidence and strengthen the safety of interventional practices.